HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Hao Selected Research

manganese dioxide

1/2018Oxygen-generating Hybrid Polymeric Nanoparticles with Encapsulated Doxorubicin and Chlorin e6 for Trimodal Imaging-Guided Combined Chemo-Photodynamic Therapy.
12/2017Erythrocyte-Membrane-Coated Prussian Blue/Manganese Dioxide Nanoparticles as H2O2-Responsive Oxygen Generators To Enhance Cancer Chemotherapy/Photothermal Therapy.
4/2017"One-for-All"-Type, Biodegradable Prussian Blue/Manganese Dioxide Hybrid Nanocrystal for Trimodal Imaging-Guided Photothermal Therapy and Oxygen Regulation of Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Hao Research Topics

Disease

39Neoplasms (Cancer)
02/2024 - 03/2007
8Hypoxia (Hypoxemia)
03/2023 - 01/2017
5Inflammation (Inflammations)
04/2024 - 11/2016
5COVID-19
02/2024 - 01/2021
5Breast Neoplasms (Breast Cancer)
12/2021 - 04/2017
5Adenocarcinoma
04/2017 - 09/2006
4Melanoma (Melanoma, Malignant)
01/2023 - 01/2018
4Cognitive Dysfunction
04/2022 - 03/2015
4Out-of-Hospital Cardiac Arrest
05/2020 - 01/2016
4Hepatocellular Carcinoma (Hepatoma)
10/2019 - 08/2007
3Atherosclerosis
04/2024 - 04/2021
3Cardiovascular Diseases (Cardiovascular Disease)
08/2023 - 01/2017
3Myocardial Infarction
03/2023 - 04/2021
3Alzheimer Disease (Alzheimer's Disease)
01/2023 - 01/2020
3Infections
01/2023 - 02/2014
3Hemorrhage
02/2021 - 07/2016
3Blindness (Hysterical Blindness)
01/2020 - 12/2005
3Lung Neoplasms (Lung Cancer)
02/2019 - 04/2017
3Stomach Neoplasms (Stomach Cancer)
01/2019 - 10/2013
3Type 2 Diabetes Mellitus (MODY)
06/2016 - 01/2014
2Colonic Neoplasms (Colon Cancer)
01/2024 - 10/2020
2Trisomy (Trisomies)
10/2023 - 01/2019
2Disease Progression
01/2023 - 02/2014
2Pathologic Processes
01/2023 - 01/2018
2Neuroinflammatory Diseases
01/2023 - 12/2022
2Ischemic Stroke
01/2023 - 04/2021
2Seizures (Absence Seizure)
11/2022 - 01/2020
2Carcinogenesis
01/2022 - 11/2016
2Osteoporosis
01/2022 - 01/2016
2Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 06/2013
2Brain Diseases (Brain Disorder)
12/2021 - 06/2013
2Chronic Kidney Failure (Chronic Renal Failure)
03/2021 - 01/2018
2Prostatic Neoplasms (Prostate Cancer)
02/2021 - 11/2016
2Neutropenia
01/2021 - 06/2014
2Hypertension (High Blood Pressure)
01/2021 - 07/2011
2Skin Neoplasms (Skin Cancer)
01/2021 - 09/2020
2Encephalitis (Encephalitis, Rasmussen)
01/2021 - 01/2020
2Neoplasm Metastasis (Metastasis)
10/2020 - 03/2013
2Retinal Degeneration
01/2020 - 12/2005
2Proteinuria
10/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2024 - 06/2004
9Biomarkers (Surrogate Marker)IBA
02/2024 - 10/2013
9Oxygen (Dioxygen)IBA
01/2024 - 04/2017
7Peptides (Polypeptides)IBA
02/2023 - 11/2016
7Therapeutic UsesIBA
02/2023 - 01/2018
7DNA (Deoxyribonucleic Acid)IBA
03/2017 - 09/2006
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 07/2014
6Hyaluronic Acid (Hyaluronan)IBA
09/2020 - 11/2016
51-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2024 - 01/2018
5HydrogelsIBA
01/2024 - 11/2016
4Retinaldehyde (Retinal)IBA
10/2023 - 06/2013
4Ethylene Glycol (Monoethylene Glycol)IBA
02/2023 - 01/2018
4CreatinineIBA
01/2023 - 02/2014
4Immune Checkpoint InhibitorsIBA
01/2023 - 01/2020
4Anti-Bacterial Agents (Antibiotics)IBA
12/2021 - 08/2011
4Hemoglobins (Hemoglobin)IBA
01/2021 - 04/2011
4MicellesIBA
07/2020 - 07/2014
32-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH)IBA
03/2024 - 10/2020
3ProdrugsIBA
01/2024 - 10/2020
3Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
01/2024 - 10/2020
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2023 - 09/2020
3Small Interfering RNA (siRNA)IBA
01/2023 - 01/2018
3Docetaxel (Taxotere)FDA Link
12/2021 - 05/2017
3AntigensIBA
10/2021 - 01/2008
3ferric ferrocyanide (Prussian blue)FDA Link
05/2020 - 04/2017
3manganese dioxideIBA
01/2018 - 04/2017
3Insulin (Novolin)FDA Link
06/2016 - 01/2014
2InflammasomesIBA
04/2024 - 07/2021
2Photosensitizing Agents (Photosensitizers)IBA
03/2024 - 02/2023
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2024 - 10/2020
2dichlorobis(azomycin)platinum IIIBA
10/2023 - 01/2019
2PlatinumIBA
02/2023 - 10/2020
2Indicators and Reagents (Reagents)IBA
01/2023 - 01/2022
2Immunoglobulins (Immunoglobulin)IBA
01/2023 - 01/2020
2trans-sodium crocetinate (crocetin)IBA
01/2023 - 03/2017
2Neuroprotective AgentsIBA
01/2023 - 01/2022
2Brain-Derived Neurotrophic Factor (BDNF)IBA
09/2022 - 04/2021
2VaccinesIBA
08/2022 - 03/2021
2Interleukin-6 (Interleukin 6)IBA
06/2022 - 02/2021
2MicroRNAs (MicroRNA)IBA
01/2022 - 01/2018
2CytokinesIBA
12/2021 - 11/2016
2Messenger RNA (mRNA)IBA
10/2021 - 04/2021
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2021 - 10/2019
2Biocompatible Materials (Biomaterials)IBA
03/2021 - 07/2020
2SolutionsIBA
01/2021 - 10/2019
2methoxy poly(ethylene glycol-co-epsilon-caprolactone)IBA
01/2021 - 09/2020
2Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 09/2020
2GoldIBA
09/2020 - 05/2017
2Rhodopsin (Visual Purple)IBA
01/2020 - 12/2005
2Protein Isoforms (Isoforms)IBA
01/2020 - 01/2017
2poly(lactide) (polylactic acid)IBA
10/2019 - 05/2017

Therapy/Procedure

28Therapeutics
04/2024 - 01/2016
14Drug Therapy (Chemotherapy)
01/2024 - 05/2017
9Immunotherapy
01/2023 - 01/2020
6Photothermal Therapy
01/2023 - 04/2017
5Photochemotherapy (Photodynamic Therapy)
03/2024 - 10/2020
3Lasers (Laser)
05/2020 - 02/2013
3Cardiopulmonary Resuscitation (CPR)
01/2017 - 01/2016
2Precision Medicine
10/2020 - 01/2018
2Injections
01/2020 - 09/2019